Musely Secures Its General Catalyst Customer Value Fund Financing
Edited by Adam Harrie — May 11, 2026 — Business
This article was written with the assistance of AI.
References: prnewswire & techcrunch
Musely, a direct-to-consumer telemedicine platform, secured $360 million from General Catalyst’s Customer Value Fund, featuring a non-dilutive, revenue-linked financing structure. The funding supports Musely’s prescription skincare, hair and menopause care offerings delivered through asynchronous consultations with licensed clinicians.
The capital functions like a capped revenue-share agreement rather than equity financing or a traditional interest-bearing loan, and Musely said the structure proved more favorable after financial modeling. The company has remained cash-flow positive since pivoting to prescription care and had avoided additional equity fundraising since its initial raise in 2014.
For consumers and DTC founders, the deal highlights an alternative growth financing path that preserves founder ownership while enabling significant investment in customer acquisition. As customer acquisition costs continue rising across direct-to-consumer health brands, revenue-linked capital presents a scalable option for expansion without surrendering control.
Image Credit: Musely
The capital functions like a capped revenue-share agreement rather than equity financing or a traditional interest-bearing loan, and Musely said the structure proved more favorable after financial modeling. The company has remained cash-flow positive since pivoting to prescription care and had avoided additional equity fundraising since its initial raise in 2014.
For consumers and DTC founders, the deal highlights an alternative growth financing path that preserves founder ownership while enabling significant investment in customer acquisition. As customer acquisition costs continue rising across direct-to-consumer health brands, revenue-linked capital presents a scalable option for expansion without surrendering control.
Image Credit: Musely
Would revenue-based funding change how founders raise money?
Helps forecast interest in revenue-linked funding, and how it could affect founders’ plans to raise, borrow, or stay bootstrapped.
1 / 3
When was the last time you looked into funding for a business?
2 / 3
If you were raising money, how likely would you use revenue-based funding?
3 / 3
Which funding path would you be most likely to choose for a new business?
Trend Themes
-
Non-dilutive Revenue-linked Financing — A shift toward capped revenue-share structures enables growth capital that preserves founder equity while aligning investor returns with company cash flows.
-
Asynchronous Telemedicine Expansion — Clinical consultations delivered outside real-time interactions create scalable care pathways that reduce overhead and increase patient throughput for specialty treatments.
-
DTC Healthcare Monetization — Direct-to-consumer health brands increasingly bundle prescription services and product sales, generating recurring revenue streams that are attractive to alternative financiers.
Industry Implications
-
Telemedicine Platforms — Platforms offering remote, asynchronous clinical services can leverage predictable revenue to qualify for revenue-linked financing and accelerate product verticalization.
-
Direct-to-consumer Health Brands — Consumer health companies with recurring prescription or subscription models stand to scale customer acquisition using non-dilutive capital while maintaining founder control.
-
Fintech Lenders and Alternative Capital — Specialized financiers can design capped revenue-share products that diversify risk profiles beyond interest-bearing loans and equity, addressing growing demand from founder-led startups.
8.3
Score
Popularity
Activity
Freshness
